An in-house study of 21 patients with EDS / POTS / Dysautonomia, studying the potential involvement of IIH (Idiopathic Intracranial Hypertension) or IIHWOP (Idiopathic Intracranial Hypertension Without Papilledema), and the effect of acetazolamide (Diamox) on symptoms.
Evaluation of potential IIHWOP in patients with EDS/POTS/Dysautonomia and treatments with acetazolamide, if indicated
by Dr. Diana Driscoll, Optometrist | Jan 31, 2021 | Clinical Trial: Status: Completed | 0 comments